These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 11559562
1. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Bai XF, Gao JX, Liu J, Wen J, Zheng P, Liu Y. Cancer Res; 2001 Sep 15; 61(18):6860-7. PubMed ID: 11559562 [Abstract] [Full Text] [Related]
2. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells. May KF, Chen L, Zheng P, Liu Y. Cancer Res; 2002 Jun 15; 62(12):3459-65. PubMed ID: 12067989 [Abstract] [Full Text] [Related]
3. Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells. Guilloux Y, Bai XF, Liu X, Zheng P, Liu Y. Cancer Res; 2001 Feb 01; 61(3):1107-12. PubMed ID: 11221840 [Abstract] [Full Text] [Related]
4. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens. Chung Y, Chang JH, Kim BS, Lee JM, Kim HY, Kang CY. Eur J Immunol; 2007 Jun 01; 37(6):1453-62. PubMed ID: 17474148 [Abstract] [Full Text] [Related]
5. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells. Robson NC, Donachie AM, Mowat AM. Eur J Immunol; 2008 May 01; 38(5):1238-46. PubMed ID: 18398931 [Abstract] [Full Text] [Related]
6. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cuenca A, Cheng F, Wang H, Brayer J, Horna P, Gu L, Bien H, Borrello IM, Levitsky HI, Sotomayor EM. Cancer Res; 2003 Dec 15; 63(24):9007-15. PubMed ID: 14695219 [Abstract] [Full Text] [Related]
7. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B. Eur J Immunol; 2009 Oct 15; 39(10):2716-24. PubMed ID: 19658094 [Abstract] [Full Text] [Related]
8. Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function. Plowden J, Renshaw-Hoelscher M, Gangappa S, Engleman C, Katz JM, Sambhara S. Cell Immunol; 2004 Jun 15; 229(2):86-92. PubMed ID: 15474523 [Abstract] [Full Text] [Related]
9. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Chamoto K, Wakita D, Narita Y, Zhang Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T. Cancer Res; 2006 Feb 01; 66(3):1809-17. PubMed ID: 16452242 [Abstract] [Full Text] [Related]
10. Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells. Stewart TJ, Smyth MJ, Fernando GJ, Frazer IH, Leggatt GR. Cancer Res; 2003 Jun 15; 63(12):3058-60. PubMed ID: 12810627 [Abstract] [Full Text] [Related]
11. Tumor antigens are constitutively presented in the draining lymph nodes. Marzo AL, Lake RA, Lo D, Sherman L, McWilliam A, Nelson D, Robinson BW, Scott B. J Immunol; 1999 May 15; 162(10):5838-45. PubMed ID: 10229818 [Abstract] [Full Text] [Related]
12. Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor tolerance. Robinson BW, Scott BM, Lake RA, Stumbles PA, Nelson DJ, Fisher S, Marzo AL. Clin Cancer Res; 2001 Mar 15; 7(3 Suppl):811s-817s. PubMed ID: 11300477 [Abstract] [Full Text] [Related]
13. Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process. Preynat-Seauve O, Contassot E, Schuler P, Piguet V, French LE, Huard B. Cancer Res; 2007 May 15; 67(10):5009-16. PubMed ID: 17510433 [Abstract] [Full Text] [Related]
14. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation. Seeley BM, Barthel SW, To WC, Kjaergaard J, Shu S, Plautz GE. Otolaryngol Head Neck Surg; 2001 Apr 15; 124(4):436-41. PubMed ID: 11283503 [Abstract] [Full Text] [Related]
15. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. Xiao Z, Curtsinger JM, Prlic M, Jameson SC, Mescher MF. Int Immunol; 2007 Jun 15; 19(6):733-43. PubMed ID: 17545279 [Abstract] [Full Text] [Related]
16. Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumor. Kedl RM, Mescher MF. J Immunol; 1997 Jul 15; 159(2):650-63. PubMed ID: 9218580 [Abstract] [Full Text] [Related]
18. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H. Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772 [Abstract] [Full Text] [Related]
19. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C. Hum Immunol; 2004 May 15; 65(5):514-22. PubMed ID: 15172452 [Abstract] [Full Text] [Related]
20. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires. Sarma S, Bai XF, Liu JQ, May KF, Zheng P, Liu Y. Cancer Res; 2003 Sep 15; 63(18):6051-5. PubMed ID: 14522934 [Abstract] [Full Text] [Related] Page: [Next] [New Search]